MMA
HALO icon

Miracle Mile Advisors’s Halozyme HALO Stock Holding History

Miracle Mile Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Hold
4,634
– – ﹤0.01% 731
2025
Q4 		$312K Buy
4,634
+45
+1% +$3.03K ﹤0.01% 694
2025
Q3 		$337K Sell
4,589
-11
-0.2% -$731 0.01% 650
2025
Q2 		$239K Buy
4,600
+151
+3% +$8.59K ﹤0.01% 645
2025
Q1 		$284K Buy
4,449
+30
+0.7% +$1.74K 0.01% 532
2024
Q4 		$211K Buy
4,419
+74
+2% +$3.79K ﹤0.01% 593
2024
Q3 		$249K Hold
4,345
– – 0.01% 460
2024
Q2 		$228K Buy
+4,345
New +$191K 0.01% 450

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Miracle Mile Advisors's HALO Position: Q1 2026 in Review

Miracle Mile Advisors held its Halozyme (HALO) position steady in Q1 2026 at 4,634 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Miracle Mile Advisors first reported a position in HALO in Q2 2024 and has held it in 8 quarters since. The position peaked at $337K in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Miracle Mile Advisors held 4,634 shares of Halozyme worth $299K as of Q1 2026.
  • Miracle Mile Advisors left its Halozyme share count unchanged in Q1 2026.
  • Halozyme made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q1 2026, its #731 holding.
  • Miracle Mile Advisors first reported a position in Halozyme in Q2 2024 and has held it in 8 quarters since.
  • Miracle Mile Advisors's Halozyme position peaked at $337K in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.